P03.11 Diffuse grade II/III astrocytomas revisited by integration of molecular markers as per WHO 2016 classification- A study of 180 cases.
Sign Up to like & getrecommendations! Published in 2017 at "Neuro-oncology"
DOI: 10.1093/neuonc/nox036.126
Abstract: AbstractThe updated WHO 2016 classification of CNS tumors combines histological and molecular features for an integrated classification. We aimed to redefine grade II/III diffuse astrocytomas earlier diagnosed as per WHO 2007 using molecular markers: IDH1/2… read more here.
Keywords: classification; idh mutant; grade iii; molecular markers ... See more keywords
WHO-2016 Classification in ALL By Cytogenetics, FISH and Molecular Biology - Experience of Two Reference Centers in Brazil
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-115426
Abstract: Introduction Almost all neoplasms have their prognosis determined by cytogenetic and molecular factors, which determines a tailored approach for each case. According to the World Health Organization, every case of Acute Lymphoblastic Leukemia (ALL) must… read more here.
Keywords: classification; age; biology; fish molecular ... See more keywords
Clinical outcomes of intracranial solitary fibrous tumor and hemangiopericytoma: analysis according to the 2016 WHO classification of central nervous system tumors.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of neurosurgery"
DOI: 10.3171/2017.7.jns171226
Abstract: OBJECTIVEThe authors conducted this retrospective study to investigate the clinical outcomes of intracranial solitary fibrous tumor (SFT) and hemangiopericytoma (HPC), defined according to the 2016 WHO classification of central nervous system (CNS) tumors.METHODSHistopathologically proven intracranial… read more here.
Keywords: hpc; sft hpc; 2016 classification; clinical outcomes ... See more keywords
Predicting survival using the 2016 World Health Organization classification for anaplastic glioma.
Sign Up to like & getrecommendations! Published in 2020 at "Clinical neuropathology"
DOI: 10.5414/np301228
Abstract: AIM This study aimed to investigate the survival and prognostic factors for anaplastic glioma, and whether the updated 2016 WHO classification had superior ability to predict survival. MATERIALS AND METHODS Between January 2001 and December… read more here.
Keywords: classification; 2016 classification; anaplastic glioma; predicting survival ... See more keywords